Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance

Go back to Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
(NASDAQ: AUTL) Delayed: 2.22 --0 (-0%)
Previous Close $2.22    52 Week High
Open $2.22    52 Week Low
Day High $2.22    P/E N/A 
Day Low $2.22    EPS
Volume 4,740